Toward a Healthier Future Through Obesity Prevention and Care: The JAMA Summit Report on Obesity.
Listen to this summary
This JAMA Summit report asks how to reduce the growing burden of obesity, which affects over 1 billion people worldwide and nearly half of U.S. adults. The authors conclude that existing prevention measures have been insufficient and that new effective medications, while promising, cannot solve the problem alone. They call for coordinated, multisector action, including food and school policies, drug evaluation modernization, payment reform, multidisciplinary care models, and efforts to reduce stigma and health inequities.
This is one of 33,000+ journals available on OSLR. Try it free for 14 days.
Free 14-day trial. 33,000+ journals. Cancel anytime.

More from JAMA
View all →Nov 19, 2026 · JAMA
Plasma eMTBR-tau as a Biomarker for Chronic Traumatic Encephalopathy Tau Tangle Neuropathology.
Nov 19, 2026 · JAMA
Medical Imaging and Pediatric and Adolescent Brain Tumor Risk.
Nov 16, 2026 · JAMA
A Plasma eMTBR-Tau Immunoassay for Detection of Advanced Insoluble Tau Pathology.
Nov 15, 2026 · JAMA
Tirzepatide in Adolescents With Obesity: The SURMOUNT-ADOLESCENTS Randomized Clinical Trial.
Nov 15, 2026 · JAMA
Once-Weekly Ribupatide for Weight Loss in Adults in China With Overweight or Obesity: The GEMINI-1 Randomized Clinical Trial.
Nov 13, 2026 · JAMA
Fluid eMTBR-tau243 as a Biomarker of Mixed 3-Repeat and 4-Repeat Tau Pathology.
More in Thoracic Surgery (Cardiothoracic Vascular Surgery)
View all →Nov 19, 2026 · Lancet (London, England)
Spontaneous coronary artery dissection: implications for women's health, clinical care, and future research.
Nov 19, 2026 · Lancet (London, England)
Reproductive health in women in Britain from 2010 to 2024: findings from repeated, cross-sectional National Surveys of Sexual Attitudes and Lifestyles (Natsal).
Nov 19, 2026 · Lancet (London, England)
Seasonal mass vaccination with R21/Matrix-M against malaria in The Gambia and Burkina Faso: an open-label, cluster-randomised, controlled trial.
Nov 19, 2026 · The New England journal of medicine
Assessing Multiple Treatment Regimens for Tuberculosis.
Nov 18, 2026 · The New England journal of medicine
Acute Respiratory Distress Syndrome.
Nov 17, 2026 · Lancet (London, England)
Natural ligand-based CAR T-cell therapy targeting BCMA and TACI for relapsed or refractory multiple myeloma (TriPRIL): a non-randomised, phase 1, first-in-human trial.
"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."
Dr. Jennifer Thompson
Portland, OR


